HBOT Conversations:
Join us for interviews with researchers, practitioners, industry experts, and patients to share their stories, successes, and expertise relative to hyperbaric oxygen therapy
Subscribe. Join the discussion. Share the hope.
Listen to or Watch the HBOT Conversations Podcast
Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or scroll down and watch an episode here on the HBOT News website:
Watch the HBOT Conversations Podcast
Subscribe Now, It’s Free !
Recent HBOT News
Persistent cauda equina syndrome with no identifiable facilitating condition after an uneventful single spinal administration of 0.5% hyperbaric bupivacaine.
Abstract: We diagnosed cauda equina syndrome 15 h after uneventful single spinal administration of 0.5% hyperbaric bupivacaine 12.5 mg through a 27-gauge pencil-point type needle. No preexisting neurologic disorder was recorded. There was no pain or paresthesia during...
Clinical Trial – Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism
This study will look at the changes taking place in the blood levels of key markers of
oxidative stress. Oxidative stress is the biological equivalent of rust on a car. It changes
vital cell chemistry. It is known to occur at high pressure oxygen, but little is known about
changes at pressures slightly greater than normal atmospheric pressure.
Hyperbaric therapy is used in a variety of medical conditions. It is being tested in this
study only for safety. It is not being assessed for the ability of hyperbaric oxygen to
improve the clinical condition of children with autism.
This study was felt to be important since autism appears to be associated with oxidative
stress and hyperbarics was being used "off-label" for this condition without safety studies.
Stem cell mobilization by hyperbaric oxygen
“We hypothesized that exposure to hyperbaric oxygen (HBO2) would mobilize stem/progenitor cells from the bone marrow by a nitric oxide (NO) -dependent mechanism”
The goal of this investigation was to determine whether exposure to hyperbaric oxygen (HBO2) would mobilize bone marrow-derived stem/progenitor cells (SPCs) in humans and animals.
Stem cell release in humans exposed to HBO2. This protocol was approved by the Institutional Review Board and by the Clinical Trials Scientific Monitoring Committee of the Abramson Cancer Center. Patients are referred to the University of Pennsylvania Institute for Environmental Medicine for prophylactic HBO2 treatment because of a risk for ORN.



